Navigation Links
United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
Date:3/25/2013

SILVER SPRING, Md., March 25, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it received a second complete response letter from the United States Food and Drug Administration (FDA) declining to approve its new drug application (NDA) for treprostinil diolamine extended release tablets (oral treprostinil) for the treatment of pulmonary arterial hypertension (PAH).

Martine Rothblatt , Ph.D., Chairman and Chief Executive Officer of United Therapeutics commented, "We remain confident that oral treprostinil will play an important role in treating PAH and we are committed to working collaboratively with the FDA to accomplish this goal in the most timely and appropriate manner."

United Therapeutics intends to immediately request an "end of review" meeting with the FDA to discuss this complete response letter.

About United Therapeutics

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.

Forward-looking Statements

Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, among others, statements regarding United Therapeutics' future efforts to gain approval of oral treprostinil, the related timing of those efforts, and actions United Therapeutics may take in response to the FDA's complete response letter.   These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could cause actual result
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DDS Lab Announces Strategic Alliance with United Concordia
2. United Spinals UsersFirst Mobilizes Wheelchair Users to Demand Access to Essential Mobility Equipment
3. United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results
4. United Therapeutics Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA
5. United BioSource Corp. erweitert mit entscheidender Neubesetzung Potenzial in Europa
6. United BioSource Corp. expande sus capacidades europeas con contrataciones clave
7. United Kingdom Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
8. United States Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
9. Kevin Johnson Joins United Allergy Services Board Of Directors
10. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
11. Oncologists in the United States and Europe Indicate that Novel Chemotherapies Hold the Most Near-Term Promise for Improving Outcomes in Soft Tissue Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015 STAAR Surgical Company ... of implantable lenses and delivery systems for the eye, today ... P. Wall to the Company,s Board. ... a Boston -based investment firm, for more ... the Board of Directors, and chair of the Corporate Governance ...
(Date:9/2/2015)... and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ) has announced the addition of ... November 26-27, 2015)" conference to their offering. ... key areas of pharmaceutical regulatory affairs in China ... Macau and Taiwan and ... gaining and maintaining a successful Marketing Authorisation in the region ...
(Date:9/2/2015)... THOUSAND OAKS, Calif. , Sept. 2, 2015 ... announced the submission of a Marketing Authorization Application ... the centralized procedure for etelcalcetide (formerly AMG 416) ... adult patients with chronic kidney disease (CKD) on ... first calcimimetic agent that can be administered intravenously. ...
Breaking Medicine Technology:William P. Wall Appointed to STAAR Surgical Board of Directors 2Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 6Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 7
(Date:9/2/2015)... ... ... an article published August 12 by International Business Times, a new bill was ... juries in cases meant to decide if a police officer used deadly or excessive force ... Ferguson and New York City that absolved police officers of charges in the deaths of ...
(Date:9/2/2015)... ... , ... Date and time: Oct. 3, 2015, 9 a.m. to 4 p.m. ... Bryn Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The Quakertown, ... author Sam Keen based on his new book which he co-authored with his son, ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... announces its latest addition to its screen mirroring and extending product line -- ... Wireless Display, which operates in local WIFI setting, the new Splashtop Wired XDisplay ...
(Date:9/2/2015)... ... September 02, 2015 , ... Michael Elliot Media announces ... a plus-size actress as the primary love interest in the film. The campaign is ... film, significantly affects how and what we think,” Michael Elliot, an award-winning screenwriter and ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Ericson is ... CDI Education Director for HCPro and Associate Director of Education for the Association for ... Advancing CDI and ICD-10 for CDI Boot Camps. She serves as a CDI subject ...
Breaking Medicine News(10 mins):Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4
... Exercise is known to have a positive effect on maintaining ... of the Journal of Thoracic Oncology has shown ... and secondary prevention of cancer. The Journal of Thoracic ... for the Study of Lung Cancer. Dr. Jennifer Temel at ...
... for All Michigan Residents Will ... recession sends record numbers of Michigan residents onto the ... health insurance, any mid-year cuts to Medicaid would harm ... hospital executives, long-term-care and mental health providers implored the ...
... Media Plays Major Role in Prompting Parent-Teen Discussions ... Dads Have Opportunity to Engage More with KidsNEW ... survey of parents, attitudes about teen drug and ... Partnership for a Drug-Free America and MetLife Foundation. ...
... -- Dr. Hisao Asamura and his team of researchers at ... records of 2,281 patients who underwent lung cancer resection surgery ... May issue of the Journal of Thoracic Oncology , ... of Lung Cancer. Dr. Asamura and his team found that ...
... NASHVILLE, Tenn., May 4 Healthcare Management Systems, Inc.(R) ... as a hospital information technology provider. HMS has ... top HIT vendors; they currently develop, sell and support ... Over the last decade, HMS has expanded its ...
... A new study on old rats by a Penn State ... heart disease and aging in women. , Heart disease is ... of 75. After menopause, women lose their ability to produce ... somehow make women more vulnerable to heart disease and heart ...
Cached Medicine News:Health News:EO Medicaid Cuts Would Harm People 2Health News:EO Medicaid Cuts Would Harm People 3Health News:National Survey: Parents Report Increased Awareness of Risks of Teen Prescription Drug Abuse, But Preventative Action Lags 2Health News:National Survey: Parents Report Increased Awareness of Risks of Teen Prescription Drug Abuse, But Preventative Action Lags 3Health News:National Survey: Parents Report Increased Awareness of Risks of Teen Prescription Drug Abuse, But Preventative Action Lags 4Health News:National Survey: Parents Report Increased Awareness of Risks of Teen Prescription Drug Abuse, But Preventative Action Lags 5Health News:Healthcare Management Systems Celebrates 25 Years 2Health News:Penn State professor investigates estrogen, heart disease connection in women 2
... Accurately tests for Nystagmus when ... 10" high by 8" diameter. Light ... ball bearings for effortless spin mechanism. ... from patient. Includes both Adult and ...
Diagnose dry eye, assess the effectiveness of permanent punctal occlusion, collagen - dissolvable in 3-5 days, all are 2 mm long. Sterile...
Clear Base Stand Magnifiers are ideal for any visual task that requires high magnification....
Contour design eyelid implants....
Medicine Products: